EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus

Ingemar Gustafsson iD, Thorbjörg Olafsdottir, Olof Neumann, Per Johansson, Dimitrios Bizios, Anders Ivarsen, Jesper Ø Hjortdal

Acta Ophthalmologica · 2025

DOI: 10.1111/aos.16736 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Ingemar Gustafsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Keratoconus, Riboflavin, Photosensitizing Agents, Cross-Linking Reagents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To present baseline characteristics and to present the perioperative corneal thickness during corneal crosslinking (CXL) treatment for progressive keratoconus and to describe how the addition of sterile water (SW) efficaciously can maintain the corneal thickness. The treatment efficacy will be evaluated when the 1‐year follow‐up is complete.

Methods

A randomised clinical study using epithelium‐off CXL with continuous UVA irradiation (9 mW/cm 2 ) and two kinds of riboflavin solutions: (i) isoosmolar dextran‐based riboflavin ( n = 27) and (ii) hypoosmolar dextran‐free riboflavin ( n = 27). Inclusion criteria: progressive keratoconus with an increase in maximum keratometry value (Kmax) of 1.0 dioptre (12 months) or 0.5 dioptres (6 months). Corneae thinner than 400 μm were also included. Outcome parameters: Perioperative corneal thickness and the effect of adding SW.

Results

Seventy‐four per cent of the patients in the isoosmolar group and 15% in the hypoosmolar group required the addition of SW, which effectively maintained a corneal thickness of 400 μm in all cases during CXL. The addition of SW was primarily needed during the irradiation procedure and not the preoperative soaking period.

Conclusions

Especially during the CXL irradiation phase, isoosmolar riboflavin causes a significant dehydrating effect leading to corneal thinning during CXL. The customised addition of SW is efficacious in maintaining the corneal thickness during CXL and could increase the safety of the procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratoconusRiboflavinPhotosensitizing AgentsCross-Linking ReagentsUltraviolet RaysPhotochemotherapyCollagenVisual AcuityCorneal TopographyHumansMaleFemaleAdultYoung AdultFollow-Up StudiesTreatment OutcomeCorneaCorneal StromaCorneal PachymetryAdolescentDisease Progression

Stichwörter der Autor:innen

corneal crosslinkingkeratoconusprogressive keratoconusriboflavin

Substanzen

RiboflavinPhotosensitizing AgentsCross-Linking ReagentsCollagen

Autor:innen und Institutionen

  • Department of Ophthalmology, Skåne University Hospital, Malmö, Sweden.
  • Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Ingemar Gustafsson

Zitieren

APA

Gustafsson, I., Olafsdottir, T., Neumann, O., Johansson, P., Bizios, D., Ivarsen, A., & Hjortdal, J. Ø. (2025). Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus. Acta Ophthalmologica. https://doi.org/10.1111/aos.16736

Vancouver

Gustafsson I, Olafsdottir T, Neumann O, Johansson P, Bizios D, Ivarsen A, et al. Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus. Acta Ophthalmologica. 2025. doi:10.1111/aos.16736

BibTeX
@article{Gustafsson2025,
  author = {Gustafsson, Ingemar and Olafsdottir, Thorbjörg and Neumann, Olof and Johansson, Per and Bizios, Dimitrios and Ivarsen, Anders and Hjortdal, Jesper Ø},
  title = {Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus},
  journal = {Acta Ophthalmologica},
  year = {2025},
  doi = {10.1111/aos.16736}
}
Kostenlos starten →